These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4834525)

  • 1. Bone disease in hemodialysis patients with particular reference to the effect of fluoride.
    Cordy PE; Gagnon R; Taves DR; Kaye M
    Can Med Assoc J; 1974 Jun; 110(12):1349-53. PubMed ID: 4834525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bone disease with dihydrotachysterol in patients undergoing long-term hemodialysis.
    Cordy PE
    Can Med Assoc J; 1977 Oct; 117(7):766-8. PubMed ID: 907948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dialysate calcium and fluoride on bone disease during regular hemodialysis.
    Jowsey J; Johnson WJ; Taves DR; Kelly PJ
    J Lab Clin Med; 1972 Feb; 79(2):204-14. PubMed ID: 5009710
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of bone disease in patients on chronic hemodialysis with dihydrotachysterol.
    Cordy PE
    Trans Am Soc Artif Intern Organs; 1976; 22():60-4. PubMed ID: 951878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoride metabolism and renal osteodystrophy in regular dialysis treatment.
    Erben J; Hájaková B; Pantůcek M; Kubes L
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():421-5. PubMed ID: 3991535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M; Chatterjee G; Cohen GF
    Ann Intern Med; 1970 Aug; 73(2):225-33. PubMed ID: 5311514
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H; Schmidberger H; Gell G
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of haemodialysis on bone in chronic renal failure.
    Bishop MC; Woods CG; Oliver DO; Ledingham JG; Smith R; Tibbutt DA
    Br Med J; 1972 Sep; 3(5828):664-7. PubMed ID: 4650845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone and bone histology: response to hypocalcemia in osteitis fibrosa.
    Voigts A; Felsenfeld AJ; Andress D; Llach F
    Kidney Int; 1984 Feb; 25(2):445-52. PubMed ID: 6727140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous calcitriol can increase bone mass in hemodialysis patients with osteitis fibrosa.
    Akiba T; Kurihara S; Yamada T; Ogasawara M; Yoneshima H; Marumo F
    Miner Electrolyte Metab; 1995; 21(1-3):109-13. PubMed ID: 7565429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fluoride on bone in chronic renal failure.
    Lough J; Noonan R; Gagnon R; Kaye M
    Arch Pathol; 1975 Sep; 99(9):484-7. PubMed ID: 1164250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and therapy of regulatory hyperparathyroidism in kidney patients].
    Koall W; Mampel E; Hintner I; Kokot F
    Z Gesamte Inn Med; 1982 Apr; 37(7):197-201. PubMed ID: 7048771
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone ultrastructure and x-ray microanalysis of aluminum-intoxicated hemodialyzed patients.
    Plachot JJ; Cournot-Witmer G; Halpern S; Mendes V; Bourdeau A; Fritsch J; Bourdon R; Druëke T; Galle P; Balsan S
    Kidney Int; 1984 May; 25(5):796-803. PubMed ID: 6471666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of osteitis fibrosa, aluminium bone disease and soft-tissue calcification in dialysis patients: a long-term comparison of moderate doses of oral calcium +/- Mg(OH)2 vs Al(OH)3 +/- 1 alpha OH vitamin D3.
    Morinière P; Boudailliez B; Hocine C; Belbrik S; Renaud H; Westeel PF; Solal MC; Fournier A
    Nephrol Dial Transplant; 1989; 4(12):1045-53. PubMed ID: 2517325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone cysts (author's transl)].
    Adler CP
    Beitr Pathol; 1973 Nov; 150(2):103-31. PubMed ID: 4768568
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes of bone histology during maintenance hemodialysis at various levels of dialyzate Ca concentration.
    Malluche HH; Ritz E; Lange HP; Schoeppe W
    Clin Nephrol; 1976 Oct; 6(4):440-7. PubMed ID: 975642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ultrastructural appearance of bone cells and bone matrix in renal osteodystrophy.
    Robinson RA
    Arch Intern Med; 1969 Nov; 124(5):519-29. PubMed ID: 5345858
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone disease in long-term haemodialysis: the association of radiological with histological abnormalities.
    Simpson W; Ellis HA; Kerr DN; McElroy M; McNay RA; Ppeart KN
    Br J Radiol; 1976 Feb; 49(578):105-10. PubMed ID: 938826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal cord compression in polyostotic fibrous dysplasia.
    Mathew NT; Bhaktaviziam A; Abraham J
    Can J Surg; 1971 May; 14(3):228-30. PubMed ID: 5578120
    [No Abstract]   [Full Text] [Related]  

  • 20. [X-ray changes in the bones of patients with chronic kidney insufficiency treated by chronic intermittent dialysis].
    Suchánek A; Adamec K; Revúsová V
    Cesk Radiol; 1973 Mar; 27(2):85-90. PubMed ID: 4694467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.